BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:378-387. [PMID: 24569821 DOI: 10.1097/meg.0000000000000065] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Peng L, Xie YF, Wang CG, Wu HG, Liu M, Wang YD, Ma FQ, Chang XR, Yang ZB. MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES. Afr J Tradit Complement Altern Med 2017;14:148-60. [PMID: 28573231 DOI: 10.21010/ajtcam.v14i2.16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Xu W, Li B, Xu M, Yang T, Hao X. Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother 2021;146:112542. [PMID: 34929576 DOI: 10.1016/j.biopha.2021.112542] [Reference Citation Analysis]
3 Migone De Amicis M, Rimondi A, Elli L, Motta I. Acquired Refractory Iron Deficiency Anemia. Mediterr J Hematol Infect Dis 2021;13:e2021028. [PMID: 34007416 DOI: 10.4084/MJHID.2021.028] [Reference Citation Analysis]
4 Yang L, Li J, Hu Z, Fan X, Cai T, Hengli Zhou, Pan H. A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine. Evid Based Complement Alternat Med 2020;2020:9154738. [PMID: 32454874 DOI: 10.1155/2020/9154738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Song M, Rabkin CS, Camargo MC. Gastric Cancer: an Evolving Disease. Curr Treat Options Gastroenterol. 2018;16:561-569. [PMID: 30361856 DOI: 10.1007/s11938-018-0203-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
6 Isajevs S, Savcenko S, Liepniece-Karele I, Piazuelo MB, Kikuste I, Tolmanis I, Vanags A, Gulbe I, Mezmale L, Samentaev D, Tazedinov A, Samsutdinov R, Belihina T, Igissinov N, Leja M. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Virchows Arch 2021. [PMID: 33990867 DOI: 10.1007/s00428-021-03116-3] [Reference Citation Analysis]
7 Jang BG, Lee BL, Kim WH. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus. PLoS One 2015;10:e0127300. [PMID: 25996368 DOI: 10.1371/journal.pone.0127300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
8 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
9 Pinzon-Guzman C, Meyer AR, Wise R, Choi E, Muthupalani S, Wang TC, Fox JG, Goldenring JR. Evaluation of Lineage Changes in the Gastric Mucosa Following Infection With Helicobacter pylori and Specified Intestinal Flora in INS-GAS Mice. J Histochem Cytochem 2019;67:53-63. [PMID: 29969055 DOI: 10.1369/0022155418785621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 He YS, Hui HY, Tan ZJ. Role of intestinal flora characteristics in traditional Chinese medicine-based diagnosis and treatment of spleen and stomach diseases. Shijie Huaren Xiaohua Zazhi 2019; 27(10): 605-610 [DOI: 10.11569/wcjd.v27.i10.605] [Reference Citation Analysis]
11 Liu ML, Qu YW, Liu HF. Application of endoscopic molecular imaging in diagnosis of gastric intestinal metaplasia. Shijie Huaren Xiaohua Zazhi 2016; 24(2): 203-208 [DOI: 10.11569/wcjd.v24.i2.203] [Reference Citation Analysis]
12 Areia M, Spaander MC, Kuipers EJ, Dinis-Ribeiro M. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk. United European Gastroenterol J. 2018;6:192-202. [PMID: 29511549 DOI: 10.1177/2050640617722902] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
13 Liu X, Zhang M, Luo R, Mo K, He X. Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China. J Int Med Res 2021;49:300060521990495. [PMID: 33631996 DOI: 10.1177/0300060521990495] [Reference Citation Analysis]
14 Costamagna G, Zullo A, Bizzotto A, Spada C, Hassan C, Riccioni ME, Marmo C, Strangio G, Di Rienzo TA, Cammarota G, Gasbarrini A, Repici A. Real-time diagnosis of H. pylori infection during endoscopy: Accuracy of an innovative tool (EndoFaster). United European Gastroenterol J. 2016;4:339-342. [PMID: 27403299 DOI: 10.1177/2050640615610021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Selgrad M, Bornschein J, Kandulski A, Weigt J, Roessner A, Wex T, Malfertheiner P. Combined Gastric and Colorectal Cancer Screening-A New Strategy. Int J Mol Sci 2018;19:E3854. [PMID: 30513960 DOI: 10.3390/ijms19123854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Enríquez-Sánchez LB, Gallegos-Portillo LG, Camarillo-Cisneros J, Cisneros-Castolo M, Montelongo-Santiesteban JJ, Aguirre-Baca DA, Pérez-Echavarría AI, Contreras-Pacheco AE. Cost-benefit of serum pepsinogen screening for gastric adenocarcinoma in the Mexican population. Rev Gastroenterol Mex (Engl Ed) 2021:S0375-0906(21)00041-0. [PMID: 34052055 DOI: 10.1016/j.rgmx.2021.01.008] [Reference Citation Analysis]
17 Quach DT, Le HM, Nguyen TS, Hiyama T. The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) Subtype among Biopsy Sites according to the Updated Sydney System and Its Association with GIM Extension. Gastroenterol Res Pract. 2018;2018:4938730. [PMID: 29853861 DOI: 10.1155/2018/4938730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Yang L, Liu W, Hu Z, Yang M, Li J, Fan X, Pan H. A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action of the Wei Pi Xiao Decoction for the Treatment of Gastric Precancerous Lesions. Evid Based Complement Alternat Med 2019;2019:1562707. [PMID: 30854000 DOI: 10.1155/2019/1562707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Hao X, Liu Y, Zhou P, Jiang Q, Yang Z, Xu M, Liu S, Zhang S, Wang Y. Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanisms of Huazhuojiedu Decoction to Treat Chronic Atrophic Gastritis. Evid Based Complement Alternat Med 2020;2020:2638362. [PMID: 33354218 DOI: 10.1155/2020/2638362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Gingold-Belfer R, Kessler-Icekson G, Morgenstern S, Rath-Wolfson L, Zemel R, Boltin D, Levi Z, Herman-Edelstein M. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation. Int J Mol Sci 2021;22:5359. [PMID: 34069715 DOI: 10.3390/ijms22105359] [Reference Citation Analysis]
21 Lam SK, Lau G. Novel treatment for gastric intestinal metaplasia, a precursor to cancer. JGH Open. 2020;4:569-573. [PMID: 32782940 DOI: 10.1002/jgh3.12318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019;13:596-603. [PMID: 31394893 DOI: 10.5009/gnl19181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Wang XQ, Li Y, Terry PD, Kou WJ, Zhang Y, Hui ZZ, Ren XH, Wang MX. Association between interleukin-21 gene rs907715 polymorphism and gastric precancerous lesions in a Chinese population. World J Gastrointest Oncol 2020; 12(3): 289-300 [PMID: 32206179 DOI: 10.4251/wjgo.v12.i3.289] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]